Medite Cancer Diagnostics, Inc. (CYOE) Financial Statements (2024 and earlier)

Company Profile

Business Address 414 NORTH ORLEANS STREET
CHICAGO, IL 60610
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2018
MRQ
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 73108587230139
Cash and cash equivalents 73108587230139
Receivables 4531,3461,7981,99110134
Inventory, net of allowances, customer advances and progress billings 2,4033,8113,0753,415
Inventory 2,4033,8113,0753,415  
Prepaid expense and other current assets10
Other undisclosed current assets 535791861545 
Total current assets: 3,4645,3445,6465,79016183
Noncurrent Assets
Property, plant and equipment 1,7781,5571,9412,091579
Intangible assets, net (including goodwill) 4,6584,6584,6582,453
Goodwill 4,6584,6584,6582,453  
Other noncurrent assets 196351273245 
Other undisclosed noncurrent assets 5,8605,8605,8605,860  
Total noncurrent assets: 12,49212,42612,73210,649579
TOTAL ASSETS: 15,95617,77018,37816,43921262
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 3,2523,3063,0324,1344,5004,773
Interest and dividends payable    445  
Taxes payable     328484
Employee-related liabilities 1,4151,335 2,0643,3242,705
Accounts payable 1,0041,093  311681
Accrued liabilities 3,2523,3063,0323,178537903
Other undisclosed accounts payable and accrued liabilities (2,419)(2,428) (1,553)  
Debt (50)(3,214)(2,857)2,5553670
Due to related parties 15414670110853,175
Other undisclosed current liabilities 4267,1095,916 (328)(484)
Total current liabilities: 3,7827,3476,1616,7994,2937,534
Noncurrent Liabilities
Long-term debt and lease obligation 4,869601211,209  
Long-term debt, excluding current maturities 4,869601211,209  
Liabilities, other than long-term debt 1,5302,3402,930   
Deferred tax liabilities, net 1,4852,2052,205   
Due to related parties 45135725   
Total noncurrent liabilities: 6,3992,4003,0511,209  
Total liabilities: 10,1819,7479,2128,0084,2937,534
Equity
Equity, attributable to parent 5,7758,0239,1668,431(4,272)(7,272)
Preferred stock 9629629621,4871,4871,487
Common stock 2923211927178
Treasury stock, value (327)(327)(327)(327)(327)(327)
Common stock, value, subscriptions  25  
Additional paid in capital 13,7509,3668,3405,76397,13793,407
Accumulated other comprehensive loss (444)(642)(609)(149)  
Retained earnings (accumulated deficit) (8,195)(1,384)7791,638(102,840)(101,917)
Total equity: 5,7758,0239,1668,431(4,272)(7,272)
TOTAL LIABILITIES AND EQUITY: 15,95617,77018,37816,43921262

Income Statement (P&L) ($ in thousands)

9/30/2018
TTM
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
 6,8139,2389,88710,98324198
Cost of revenue (6,651)(5,608)(6,084)(7,164)(8)(104)
Gross profit: 1623,6303,8033,8191694
Operating expenses (1,481)(1,691)(1,455)(1,566)(908)(1,576)
Other undisclosed operating income (loss) (5,161)(3,600)(2,947)(2,647)74213
Operating loss: (6,480)(1,661)(599)(394)(818)(1,269)
Nonoperating expense (818)(634)(182)(201)(105)(245)
Other nonoperating income 189602275  
Interest and debt expense (158)(20)(2) 117323
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 158202 (117)(323)
Loss from continuing operations before income taxes: (7,298)(2,295)(781)(595)(923)(1,514)
Income tax expense (benefit) 487132(78)(104)  
Loss from continuing operations: (6,811)(2,163)(859)(699)(923)(1,514)
Loss before gain (loss) on sale of properties: (6,811)(2,163)(859)(699)(923)(1,514)
Net loss attributable to parent: (6,811)(2,163)(859)(699)(923)(1,514)
Preferred stock dividends and other adjustments (91)(91)(78)(109)(266)(266)
Net loss available to common stockholders, diluted: (6,902)(2,254)(937)(808)(1,189)(1,780)

Comprehensive Income ($ in thousands)

9/30/2018
TTM
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss: (6,811)(2,163)(859)(699)(923)(1,514)
Other comprehensive income (loss) 198(33)(460)   
Comprehensive loss: (6,613)(2,196)(1,319)(699)(923)(1,514)
Other undisclosed comprehensive loss, net of tax, attributable to parent    (436)  
Comprehensive loss, net of tax, attributable to parent: (6,613)(2,196)(1,319)(1,135)(923)(1,514)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: